Disposición a pagar por vacunas contra el virus papiloma humano en la Región Metropolitana de Santiago de Chile
Open Access
- 1 February 2013
- journal article
- abstracts
- Published by SciELO Agencia Nacional de Investigacion y Desarrollo (ANID) in Revista médica de Chile
- Vol. 141 (2) , 167-172
Abstract
Background: Human papillomavirus (HPV) infection is a risk factor for cervical cancer and can be prevented with the HPV vaccine. Aim: To explore the willingness of parents to pay for HPV vaccine for their offspring. Material and Methods: A survey about the willingness to pay for HPV vaccine was answered by 386 individuals of the highest socioeconomic level who had a daughter aged between 12 and 18 years. The survey included information about the risks of HPV infection. Results: Parents would pay a mean of US$ 758 for the vaccine. Twenty five percent of parents were not willing to pay for it. If the cost of the vaccine would be reduced by 50%, only 4% of parents would not pay for it. The willingness to pay is associated with the price of the vaccine, the income level of respondents and the size of the family. Conclusions: Most respondents would pay for HPV vaccine for their daughters, despite the relatively high cost.Keywords
This publication has 12 references indexed in Scilit:
- Mothers’ preferences and willingness to pay for vaccinating daughters against human papillomavirusVaccine, 2010
- Prevalence of HPV Infection among Men: A Systematic Review of the LiteratureThe Journal of Infectious Diseases, 2006
- Parental Attitudes About Sexually Transmitted Infection Vaccination for Their Adolescent ChildrenArchives of Pediatrics & Adolescent Medicine, 2005
- Human Papillomavirus Vaccine Acceptability Among Parents of 10- to 15-Year-Old AdolescentsJournal of Lower Genital Tract Disease, 2004
- Parental perspectives on vaccinating children against sexually transmitted infectionsSocial Science & Medicine, 2004
- Costs and benefits of cervical screening IV: valuation by women of the cervical screening programmeCytopathology, 2001
- Human papillomavirus and cancer: the epidemiological evidenceJournal of Clinical Virology, 2000
- Acceptability of Human Papillomavirus ImmunizationJournal of Women's Health & Gender-Based Medicine, 2000
- Optimal Bid Selection for Dichotomous Choice Contingent Valuation SurveysJournal of Environmental Economics and Management, 1993
- Statistical Efficiency of Double‐Bounded Dichotomous Choice Contingent ValuationAmerican Journal of Agricultural Economics, 1991